|
We recommend that authors read the following instructions carefully before
submitting their manuscripts to Cadernos de Saúde Pública.
1. CSP accepts articles for the following sections:
1.1 Literature reviews - critical reviews of the literature on
themes pertaining to public health (maximum 8,000 words and 5 figures);
1.2 Articles - results of empirical, experimental, or conceptual
research (maximum 6,000 words and 5 figures);
1.3 Notes - advance notes reporting on partial or preliminary research
results (maximum 1,700 words and 3 figures);
1.4 Book reviews - critical reviews of books related to the thematic
scope of CSP, published in the previous two years (maximum 1,200 words);
1.5 Letters - critiques of articles published in previous issues
of CSP (maximum 1,200 words and 1 figure);
1.6 Debate - theoretical articles accompanied by critical letters
signed by authors from other institutions and invited by the Editor, followed
by a reply from the author of the main article (maximum 6,000 words and
5 figures);
1.7 Forum - section that publishes sets of 2 to 3 interrelated
articles by different authors, on a theme of current interest (maximum
12,000 words for the combined articles). Authors interested in submitting
work to this section should consult the CSP Editorial Board.
2. Presentation of manuscripts
2.1CSP only considers publishing original, previously unpublished
manuscripts that are not being reviewed simultaneously for publication
by any other journal. Authors must state these conditions in the submission
process. In case previous publication or simultaneous submission to another
journal is identified, the article will be rejected. Duplicate submission
of a scientific manuscript constitutes a serious breach of ethics by the
author(s).
2.2 Submissions are accepted in Portuguese, Spanish, or English.
2.3 Footnotes and attachments will not be accepted.
2.4 The word count includes the body of the text and references
as specified in item 12.13.
3. Publication of clinical trials
3.1 Manuscripts presenting partial or complete results of clinical
trials must include the number and name of the agency or organization
where the clinical trial is registered.
3.2 This requirement complies with recommendations by BIREME/PAHO/WHO
on the Registration of Clinical Trials to be published based on the guidelines
of the World Health Organization (WHO), the International Committee of
Medical Journal Editors, and the ICTPR Workshop.
3.3 Agencies and organizations that register clinical trials according
to ICMJE criteria include:
a) Australian
New Zealand Clinical Trials Registry (ANZCTR)
b) ClinicalTrials.gov
c) International
Standard Randomised Controlled Trial Number (ISRCTN)
d) Nederlands
Trial Register (NTR)
e) UMIN Clinical
Trials Registry (UMIN-CTR)
f) WHO International
Clinical Trials Registry Platform (ICTRP)
4. Funding sources
4.1 Authors must disclose all sources of institutional or private
funding or support for conducting the study.
4.2 Suppliers of free or discount materials or equipment should
be disclosed as funding sources, including the origin (city, state, and
country).
4.3 If the study has been performed without institutional and/or
private funding, the authors should state that the research did not receive
any funding.
5. Conflicts of interests
5.1 Authors must disclose any potential conflicts of interest,
including political and/or financial interests associated with patents
or property and manufacturer's supply of materials and/or inputs and equipment
used in the study.
6. Authors
6.1 The various authors' individual contributions to the elaboration
of the article should be specified.
6.2 We emphasize that the authorship criteria should be based on
the uniform requirements of the International
Committee of Medical Journal Editors, which establish the following:
recognition of authorship should be based on substantial contributions
to the following: 1. conception and design, acquisition of data, or analysis
and interpretation of data; 2. drafting the article or revising it critically
for important intellectual content; 3. final approval of the version to
be published. Authors should meet all three conditions.
7. Acknowledgements
7.1 otential acknowledgements include institutions that in some
way allowed or facilitated the research and/or persons that collaborated
with the study but fail to meet the authorship criteria.
8. References
8.1 References should be numbered consecutively in the order in
which they first appear in the text. They should be identified by superscript
Arabic numerals (e.g.: Silva1). References cited only in tables
and figures should be numbered starting after the last reference cited
in the text. Cited references should be listed at the end of article,
in numerical order, following the Uniform Requirements for Manuscripts
Submitted to Biomedical Journals (http://www.nlm.nih.gov/citingmedicine/).
8.2 All references should be presented in correct and complete
form. The veracity of the information contained in the list of references
is the responsibility of the author(s).
8.3 In case any reference management software like EndNote is used, the
author(s) should convert the references to text.
9. Nomenclature
9.1 The manuscript should comply with the rules of zoological
and botanical nomenclature, as well as with the abbreviations and conventions
adopted in the specialized fields.
10. Ethics in research involving human subjects
10.1 The publication of articles with results of research involving
human subjects is conditioned on compliance with the ethical principles
contained in the Helsinki
Declaration (1964, revised in 1975, 1983, 1989, 1996, and 2000), of
the World Medical Association.
10.2 In addition, the research must comply with the specific legislation
(when existing) of the country in which the research was performed.
10.3 Articles that present the results of research involving human
subjects must contain a clear statement of this compliance (this statement
should be the last paragraph of the manuscript's Methodology section).
10.4 After the manuscript is accepted for publication, all the
authors must sign a specific form, to be provided by the Editorial Secretariat
of CSP, stating their full compliance with the ethical principles and
specific legislations.
10.5 The Editorial Board of CSP reserves the right to request additional
information on the ethical principles adopted in the research.
11. On-line submission process
11.1 Articles should be submitted electronically through the System
for Article Review and Management (SAGAS), available at: http://www.ensp.fiocruz.br/csp/.
No other forms of submission will be accepted. The following are complete
instructions for submission. In case of doubt, kindly contact the SAGAS
support system at the following e-mail: csp-artigos@ensp.fiocruz.br.
11.2 The author should begin by entering SAGAS at http://www.ensp.fiocruz.br/csp/.
Next, key in the user name and password to go to the restricted article
management area. New users of SAGAS should register through the "Register"
link on the homepage. In case you have forgotten your password, request
that it be sent automatically as follows: "Forget your password?
Click here."
11.3 For new users of SAGAS. After clicking on "Register",
you will be directed to the SAGAS registry. Key in your name, address,
e-mail, telephone, and institution.
12. Sending the article
12.1 On-line submission is done in the restricted article management
area http://www.ensp.fiocruz.br/csp/.
The author should access "Author Central" and select the link
"Submit a new article".
12.2 The first stage in the submission process consists of checking
the CSP Instructions to Authors.
The manuscript will only be considered by the CSP Editorial Secretariat
if it meets all the uniform requirements for publication.
12.3 During the second stage, all data referring to the article
will be keyed in: title, running title, field, key words, disclosure of
funding and conflicts of interest, abstract in the original language and
English, and acknowledgements when necessary. If they wish, authors may
suggest potential consultants (name, e-mail, and institution) whom they
consider capable of reviewing the manuscript.
12.4 The complete title (in the original language and English)
should be concise and informative, with a maximum of 150 characters with
spaces.
12.5 The running title (in the original language) may contain a
maximum of 70 characters with spaces.
12.6 The key words (minimum of 3, maximum of 5, in the article's
original language) should appear in the Biblioteca Virtual em Saúde/Virtual
Health Library (BVS), available at: http://decs.bvs.br/.
12.7 Abstract. With the exception of contributions submitted
to the Book Review or Letters sections, all articles submitted in Portuguese
or Spanish should include an abstract in the original language and in
English. Articles submitted in English should include an abstract in Portuguese
or Spanish, in addition to the abstract in English. The abstract should
have a maximum of 1,100 characters with spaces.
12.8 Acknowledgements. The acknowledgements of institutions
and/or individuals may contain a maximum of 500 characters with spaces.
12.9 The third stage includes the full name(s) of the article's
author(s) and respective institutions(s), with the complete address, telephone,
and e-mail, as well as a specification of each author's contribution.
The author that registers the article will automatically be included as
an author. The order of the authors' names should be the same as in the
publication.
12.10 The fourth stage is the file transfer with the body of the
text and references.
12.11 The file containing the manuscript text should be formatted
in DOC (Microsoft Word), RTF (Rich Text Format), or ODT (Open Document
Text), and may not exceed 1 MB.
12.12 The text should be formatted with 1.5cm spacing, font Times
New Roman, size 12.
12.13 The text file should contain only the body of the article
and the bibliographic references. The following items should be inserted
in separate fields during the submission process: abstract in the original
language and English; name(s) of the author(s), plus institutional affiliation
or any other information that identifies the author(s); acknowledgments
and contributions; illustrations (photographs, flowcharts, maps, graphs,
and tables).
12.14 The fifth stage includes transferring the files with the
article's illustrations (photographs, flowcharts, maps, graphs, and tables),
when necessary. Each illustration should be sent in a separate file, clicking
on "Transfer"
12.15 Illustrations. Illustrations should be kept to a minimum,
allowing a maximum of five (photographs, flowcharts, maps, graphs, and
tables).
12.16 Authors will cover the costs of illustrations beyond the
maximum number of five, as well as any extra costs for publishing color
figures.
12.17 Authors should obtain written authorization from any respective
copyright holders to reproduce previously published illustrations.
12.18 Tables. Tables may be 17cm wide, considering a size
9 font. They should be submitted in text file: DOC (Microsoft Word), RTF
(Rich Text Format), or ODT (Open Document Text). Tables should be numbered
(Arabic numerals) according to the order in which they appear in the text.
12.19 Figures. The following types of figures will be allowed
by CSP: Maps, Graphs, Satellite Images, Photographs, Flow Diagrams, and
Flowcharts.
12.20 Maps should be submitted in vector format, and the
following types of files are allowed: WMF (Windows MetaFile), EPS (Encapsuled
PostScript), or SVG (Scalable Vectorial Graphics). Note: maps originally
generated in raster or image format and later exported to vector format
will not be accepted.
12.21 Graphs should be submitted in vector format and will
be allowed in the following types of files: XLS (Microsoft Excel), ODS
(Open Document Spreadsheet), WMF (Windows MetaFile), EPS (Encapsuled PostScript),
or SVG (Scalable Vectorial Graphics).
12.22 Satellite images and photographs should be submitted in the
following types of files: TIFF (Tagged Image File Format) or BMP (Bitmap).
Minimum resolution should be 300dpi (dots per inch), with a minimum width
of 17.5cm.
12.23 Flow diagrams and flowcharts should be submitted in text
file or in vector format and will be allowed in the following types of
files: DOC (Microsoft Word), RTF (Rich Text Format), ODT (Open Document
Text), WMF (Windows MetaFile), EPS (Encapsuled PostScript), or SVG (Scalable
Vectorial Graphics).
12.24 Figures should be numbered (Arabic numerals) according to
the order in which they appear in the text.
12.25 Titles and legends of figures should be presented in a text
file separate from the figure files.
12.26 Vector format. A vector drawing is generated based
on geometric descriptions of shapes and normally consists of curves, ellipses,
polygons, text, and other elements, i.e., using mathematical vectors for
its description.
12.27 Completion of Submission. Upon completing the entire
file transfer process, click on "Complete Submission"
12.28 Confirmation of Submission. After completing the submission,
the author will receive an e-mail message confirming receipt of the article
by CSP. In case you do not receive the e-mail confirmation within 24 hours,
contact the CSP Editorial Secretariat by e-mail: csp-artigos@ensp.fiocruz.br.
13. Monitoring the article review process
13.1 Authors can monitor the article's editorial flow through
the SAGAS system. Decisions on the article will be communicated by e-mail
and made available in the SAGAS system.
13.2 Contacts with the CSP Editorial Secretariat should be via the SAGAS
system.
14. Sending new versions of articles
14.1 New versions of the article may be submitted by using the
restricted article management area in the SAGAS system, accessing the
article and clicking on the "Submit New Version".
15. Electronic page proof
15.1 Following acceptance of the article, an electronic page proof
will be sent to the corresponding author by e-mail. Adobe Reader is needed
to view the proof. This software can be downloaded free of cost from:
http://www.adobe.com/products/acrobat/readstep2.html.
15.2 The revised proof and properly signed declarations should
be sent to the CSP Editorial Secretariat by e-mail (cadernos@ensp.fiocruz.br)
or fax +55(21)2598-2514 within 72 hours after receipt by the corresponding
author.
|
|
